Orexo AB (FRA:C5G)
€ 1.252 -0.02 (-1.57%) Market Cap: 44.09 Mil Enterprise Value: 74.39 Mil PE Ratio: 0 PB Ratio: 21.37 GF Score: 65/100

Orexo AB at OTC Markets Life Science Investor Forum Transcript

Jun 22, 2023 / 01:30PM GMT
Release Date Price: €0.742 (-1.20%)
John Viglotti
OTC Markets Group Inc. - Analyst

Hello, and welcome to the vir1tual investor conferences. My name is John Viglotti. On behalf of OTC Markets, we're very pleased you joined us for our Life Sciences Investor Forum. We'll start the day off with a live presentation from Orexo, who's developing solutions for mental health and substance use disorders.

(Event Instructions) At this point, I'm very pleased to welcome, Nikolaj Sørensen. He's the President and Chief Executive Officer of Orexo, which trades on the OTCQX Best Market under the symbol ORXOY and on Nasdaq Stockholm under the symbol ORX. Welcome back, Nicolaj.

Nikolaj SÃ;rensen
Orexo AB - President & CEO

¸ -

Thank you very much. It's a pleasure to be here again. And I look forward to present Orexo, which is a commercial stage company. And just as you said, John, we are focusing on the opioid use disorder market, in particular, being one of the few companies who are developing new medications, new solutions, and also have a product in the market to help the strategy

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot